Navigation Links
Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1)
Date:4/30/2009

Sanuvox UV Air Sterilization Systems are designed to destroy airborne biological contaminants including swine influenza (H1N1 virus).

Montreal, Canada (PRWEB) April 30, 2009 -- Sanuvox Technologies has been receiving inquiries following the recent swine influenza (H1N1 virus) outbreak in Mexico, United States, and Canada as well as in other parts of the world. Sanuvox UV Air Sterilization Systems are designed to destroy airborne biological contaminants including swine influenza.

Sanuvox wants to inform the public on the ability of Sanuvox Ultraviolet Air Sterilization Systems to destroy the influenza virus including those that fall into the family of Orthomyxoviridae. These include type A, type B and type C influenza viruses. The World Health Organization has confirmed that these cases are a never-before-seen version of the H1N1 strain of the influenza type A virus.

Using proprietary UV technology, the Sanuvox In-Duct Ultraviolet Air Sterilization System is designed to maximize exposure time between the air and the UV germicidal energy. The UV system delivers the optimal UV dosage penetrating the cell membrane destroying the DNA structure of the virus.

The Sanuvox UV Bio-Wall In-Duct Air Sterilizer has been tested by the US Environmental Protection Agency (EPA) and the US National Homeland Security Research Center (NHSRC) against biological warfare agents. Installed into the ventilation system, the Sanuvox UV Air Sterilization unit achieved on a single pass with no recirculation >99.97% destructio
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
2. US Female Sterilization Market to Grow to Almost $245 Million Over the Next Five Years
3. Environmental Tectonics Corporations Sterilization Systems Group Announces the Receipt of Three New Contracts
4. Is Permanent Sterilization Permanent?
5. STERIS Isomedix Services Offers Medical Device Sterilization Seminar
6. STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter
7. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
8. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
9. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
10. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
11. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1)
Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1)
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 1Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 2Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 3Abaxis Inc to Present at the 21st Annual Piper Jaffray Health Care Conference 6535 1Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6531 1